- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Video
Expert Insights into Duration of Treatment for Hedgehog vs Immunotherapy
Author(s):
An expert in dermatology shares her insights into the duration of treatment and dose adjustments for systemic treatments in patients with basal cell carcinoma.
Video Player is loading.
Related Videos
Data Review of 2 doses of Sonidegib in Advanced Basal Cell Carcinoma (BOLT Trial)
Expert Perspectives on EVRIANCE clinical trial data
Data Review of the Efficacy and Safety of Vismodegib in Advanced Basal Cell Carcinoma (EVRIANCE Trial)
Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma
Expert Insights Into Locally Advanced Basal Cell Carcinoma
Management of Newly Diagnosed Patients with Basal Cell Carcinoma (BCC)
Treatment Considerations and Management of Adverse Events when Treating BCC
Efficacy and Safety of Combination Treatments for BCC
Developing a Multidisciplinary Approach when Treating BCC
Expert Perspectives in Locally Advanced Basal Cell Carcinoma (BCC) Treatment Options
Related Content
